MySpace: the Role of Vision in Representing Space
Launched by ISTITUTO ITALIANO DI TECNOLOGIA · Apr 9, 2024
Trial Information
Current as of July 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
MySpace is an interventional neuropsychology study purely for scientific purposes, with no diagnostic or therapeutic aims. The project aims to define the role of vision in generating uni- and multi-sensory spatial representations (audio/tactile), essential for proper interaction with the surrounding environment. The project will focus on studying spatial deficits and reorganization mechanisms present in the absence of vision from the early years of development. The results will allow drawing overall conclusions on how we perceive the world and develop rehabilitative protocols to improve the...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having provided (by the subject or the parent/guardian) consent to be contacted through one of the recruitment channels established by the Italian Institute of Technology or voluntary enrollment;
- • Signature of the informed consent (by the subject or the parent/guardian);
- • Absence of other disabilities/conditions/comorbidities that would prevent participation and/or ensure patient safety during the execution of the tests and/or guarantee the quality/reliability of the data. This point is acquired through Informed Consent, in the section expressly acknowledging the following reasons for ineligibility to participate in the study: tactile hypersensitivity (specifically assessing equipment tolerance), taking neuroactive drugs and substances and having taken them in the last six months, comorbidity with another pathology;
- • Being affected, to the best of their knowledge, by pathologies of the central nervous system, and having experienced epileptic episodes, even minor ones, and convulsive crises in general, even in childhood;
- • The participating subjects may have typical or atypical development (i.e., group with visual disability). In the case of visual impairment, the disability should be congenital (from birth) or late onset. Furthermore, the following requirements must be met: subjects with visual disabilities must be classified according to current diagnostic rules, with visual problems present from birth or occurring later, with residual vision ranging from 0.5-1.3 LogMAR in the case of low vision or lower than 1.3 LogMAR in the case of blindness;
- * Age range required for each phase and configuration: Blind adults (≥ 18 years old):
- • Phase 1; Phase 2; Phase 3; Typical adults (≥ 18 years old): Phase 1; Phase 2; Phase 3; Blind minors (3 months \< age \< 18 years old): All phases; Typical minors (3 months \< age \< 18 years old): All phases; Adequate cognitive capacity for age. In particular, recognized scales such as the WISC9 scale will be used as a reference parameter to assess cognitive capacity.
- Exclusion Criteria:
- • Additional disabilities besides visual impairment (e.g., individuals who are both visually and hearing impaired);
- • Absence of the signature on the informed consent form or incomplete consent regarding acknowledgment of the incompatibilities for participation in the study;
- • IQ values below the threshold of normality according to one of the recognized international scales;
- • Preterm birth.
About Istituto Italiano Di Tecnologia
The Istituto Italiano di Tecnologia (IIT) is a leading research institution in Italy, dedicated to advancing scientific knowledge and technological innovation in various fields, including life sciences, robotics, and nanotechnology. With a strong emphasis on interdisciplinary collaboration, IIT fosters cutting-edge research and development aimed at enhancing human health and quality of life. The institute actively engages in clinical trials and studies, leveraging its expertise to translate scientific discoveries into practical applications. By promoting a culture of innovation and excellence, IIT plays a pivotal role in driving progress in healthcare and biomedical research on both national and international stages.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Genova, , Italy
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported